SIGA Technologies, Inc. (SIGA)
3.06
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
3.06
0.00 (0.00%)
After-Hours: 20:00
SIGA Technologies EPS Diluted (Quarterly) : 0.1734 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1734 |
| March 31, 2026 | -0.0482 |
| December 31, 2025 | -0.0758 |
| September 30, 2025 | -0.0889 |
| June 30, 2025 | 0.4946 |
| March 31, 2025 | -0.0057 |
| December 31, 2024 | 0.6409 |
| September 30, 2024 | 0.0187 |
| June 30, 2024 | 0.0255 |
| March 31, 2024 | 0.1436 |
| December 31, 2023 | 1.016 |
| September 30, 2023 | -0.0055 |
| June 30, 2023 | -0.0404 |
| March 31, 2023 | -0.0127 |
| December 31, 2022 | -0.0112 |
| September 30, 2022 | 0.451 |
| June 30, 2022 | 0.0271 |
| March 31, 2022 | -0.0096 |
| December 31, 2021 | 0.9716 |
| September 30, 2021 | -0.0416 |
| June 30, 2021 | -0.0034 |
| March 31, 2021 | -0.0106 |
| December 31, 2020 | 0.2579 |
| September 30, 2020 | 0.3094 |
| June 30, 2020 | 0.2594 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1095 |
| December 31, 2019 | -0.0554 |
| September 30, 2019 | -0.0266 |
| June 30, 2019 | -0.0465 |
| March 31, 2019 | -0.0183 |
| December 31, 2018 | 0.65 |
| September 30, 2018 | 4.707 |
| June 30, 2018 | -0.0891 |
| March 31, 2018 | -0.1465 |
| December 31, 2017 | -0.13 |
| September 30, 2017 | -0.12 |
| June 30, 2017 | -0.0952 |
| March 31, 2017 | -0.1094 |
| December 31, 2016 | -0.15 |
| September 30, 2016 | -0.17 |
| June 30, 2016 | -0.18 |
| March 31, 2016 | -0.19 |
| December 31, 2015 | -0.3713 |
| September 30, 2015 | -0.10 |
| June 30, 2015 | -0.12 |
| March 31, 2015 | -0.13 |
| December 31, 2014 | -0.36 |
| September 30, 2014 | -4.49 |
| June 30, 2014 | -0.06 |
| March 31, 2014 | -0.06 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.46M |
| Revenue (Quarterly) | 41.00M |
| Total Expenses (Quarterly) | 28.54M |
| Enterprise Value | 102.70M |
| Gross Profit Margin (Quarterly) | 57.17% |
| Profit Margin (Quarterly) | 30.40% |
| Earnings Yield | -1.29% |
| Normalized Earnings Yield | -1.294 |